Atlas Trials

Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia

Clinical trial NCT07499349 · RECRUITING

Trial details

NCT number
NCT07499349
Sponsor
Aarhus University Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Acute Lymphoblastic Leukemia
Start date
2008-07-01
Primary completion
2026-06-30
Enrollment
475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.